India's drug regulator, the DCGI, is set to meet with cosmetics industry representatives to address regulatory concerns. The industry seeks clarification on Schedule M, which proposes a ban on manufacturing non-drug items in drug manufacturing units, potentially impacting cosmetics production.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.